Research is being conducted on the genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia. Studies are providing insights into the transcriptomic signatures, clonal origin, and potential therapeutic options for this type of leukemia. The research includes single-cell transcriptomics, genomic frameworks, and investigations into potential treatments such as menin inhibitors and proteasome inhibition.